Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors | Zendy

Theresa Hahn | Zendy; Philip L. McCarthy | Zendy; Anna Hassebroek | Zendy; Christopher Bredeson | Zendy; James Gajewski | Zendy; Gregory A. Hale | Zendy; Luis Isola | Zendy; Hillard M. Lazarus | Zendy; Stephanie J. Lee | Zendy; Charles F. LeMaistre | Zendy; Fausto R. Loberiza | Zendy; Richard T. Maziarz | Zendy; J. Douglas Rizzo | Zendy; Steven Joffe | Zendy; Susan K. Parsons | Zendy; Navneet S. Majhail | Zendy

Open Access

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors

Author(s) -

Theresa Hahn,

Philip L. McCarthy,

Anna Hassebroek,

Christopher Bredeson,

James Gajewski,

Gregory A. Hale,

Luis Isola,

Hillard M. Lazarus,

Stephanie J. Lee,

Charles F. LeMaistre,

Fausto R. Loberiza,

Richard T. Maziarz,

J. Douglas Rizzo,

Steven Joffe,

Susan K. Parsons,

Navneet S. Majhail

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.46.6193

Subject(s) - medicine , transplantation , cord blood , myelodysplastic syndromes , hematopoietic stem cell transplantation , population , myeloid leukemia , surgery , myeloid , cohort , bone marrow , environmental health

Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases. This study describes changes in use, technique, and survival in a population-based cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research